This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Myxomatosis | |
|---|---|
| Name | Myxomatosis |
| Field | Virology, Veterinary medicine |
| Symptoms | Conjunctivitis, edema, nodules, lethargy |
| Complications | Secondary bacterial infection, dehydration |
| Onset | Variable |
| Duration | Weeks |
| Causes | Myxoma virus (Poxviridae) |
| Risks | Contact with vectors, rabbit density, introduced species |
| Diagnosis | PCR, histopathology, clinical signs |
| Treatment | Supportive care, antibiotics for secondary infection |
| Prevention | Vaccination, vector control, biosecurity |
| Frequency | Endemic in many regions |
Myxomatosis is an infectious disease of lagomorphs characterized by severe cutaneous and systemic lesions caused by a poxvirus, historically notable for dramatic population impacts on wild and domestic rabbits during deliberate and natural outbreaks. The disorder has influenced veterinary practice, wildlife management, and international policy responses, prompting extensive study across virology, ecology, and conservation fields. Research has involved collaborations among institutions, laboratories, and governments to assess virus evolution, host resistance, and control strategies.
The disease emerged in scientific and policy debates following experiments and releases in the early 20th century that intersected with work at institutions such as the Commonwealth Scientific and Industrial Research Organisation, University of Cambridge, and Imperial College London, and influenced conservation efforts linked to agencies like the Ministry of Agriculture, Fisheries and Food and the Department of Agriculture, Fisheries and Forestry (Australia). Historical accounts reference episodes in countries including Australia, United Kingdom, France, Spain, Portugal, and New Zealand where introductions altered ecosystems and prompted legislative responses from bodies such as the European Commission and national parliaments. Notable scientists and administrators in the narrative include figures associated with the Sussex University, CSIRO, and research groups at the Institut Pasteur and Wageningen University. The social and economic consequences reverberated through rural industries, land management policies, and international trade agreements administered by organizations like the Food and Agriculture Organization and the World Organisation for Animal Health.
Etiologic studies identify the causal agent as a member of the family Poxviridae within the genus Leporipoxvirus, closely related to viruses studied at the National Institutes of Health, Centers for Disease Control and Prevention, and university virology centers such as University of California, Davis and University of Glasgow. Genomic analyses conducted with contributions from laboratories at the Sanger Institute, Max Planck Institute, and Harvard Medical School have elucidated virulence genes and evolutionary dynamics, with comparative work referencing viruses like Vaccinia virus, Variola virus, and other poxviruses characterized by teams at the Rockefeller University and Yale School of Medicine. The virus replicates in cytoplasmic factories and encodes immunomodulatory proteins investigated using methods developed at institutions including Cold Spring Harbor Laboratory and Karolinska Institutet.
Transmission is mediated by arthropod vectors and contact routes documented in field studies by researchers affiliated with CSIRO, British Trust for Ornithology, RSPCA, and university wildlife units at University of Oxford and University of Bristol. Vectors implicated in spread include fleas, mosquitoes, and mites examined in entomological surveys by teams from London School of Hygiene & Tropical Medicine, Institut Pasteur, and Monash University. Epidemiologic patterns have been assessed through collaborations between agencies such as the European Centre for Disease Prevention and Control, Scottish Government, and regional conservation bodies like National Trust (United Kingdom), revealing host population cycles and spatial dynamics influenced by climatic events catalogued by Met Office (United Kingdom) and Bureau of Meteorology (Australia).
Clinically, affected lagomorphs exhibit conjunctivitis, myxomas, subcutaneous edema, and nodular lesions described in pathology reports from veterinary hospitals affiliated with Royal Veterinary College, University of Sydney, Colorado State University, and Cornell University. Histopathologic features and immune responses have been characterized in studies by investigators at Johns Hopkins University, University of Toronto, and University of Edinburgh, with lesions reflecting virus-host interactions similar to those studied in comparative pathology at Max Planck Institute for Evolutionary Biology and Smithsonian Institution research programs.
Diagnostic approaches utilize polymerase chain reaction assays and sequencing capacity provided by reference laboratories such as APHA (Animal and Plant Health Agency), Veterinary Laboratories Agency, and university molecular labs at University of Melbourne and University of Pretoria, with immunohistochemistry protocols derived from methods developed at Mayo Clinic and University College London. Differential diagnoses considered by clinicians include bacterial respiratory syndromes and other viral diseases historically investigated at centers like Pasteur Institute of Lille, Institut Pasteur de Montevideo, and wildlife disease units within Australian Department of Agriculture.
Treatment is primarily supportive, involving fluid therapy, nutritional support, and antibiotics for secondary infections administered in clinical settings such as Royal Veterinary College Hospital, Anglia Veterinary Hospital, and veterinary clinics associated with UFAW. Experimental therapies and antiviral research have engaged teams at GlaxoSmithKline, Pfizer, and university research groups including University of São Paulo and Seoul National University, while animal welfare organizations like RSPCA and WWF provide guidance on field management and humane considerations.
Prevention relies on vaccination campaigns, vector control strategies, and biosecurity measures coordinated by authorities including the World Organisation for Animal Health, DEFRA, NSW Department of Primary Industries, and regional conservation trusts like National Parks and Wildlife Service (New South Wales). Vaccines developed and licensed with involvement from pharmaceutical regulators such as the European Medicines Agency and Therapeutic Goods Administration (Australia) complement integrated pest management approaches promoted by research centers like CSIRO and CABI. Population management, policy decisions, and international collaboration continue to be informed by monitoring from institutions including the Joint Nature Conservation Committee, IUCN, and national biodiversity centers.
Category:Viral diseases